摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(3-chloro-phenyl)-N-methoxy-N-methyl-acrylamide | 701914-01-4

中文名称
——
中文别名
——
英文名称
3-(3-chloro-phenyl)-N-methoxy-N-methyl-acrylamide
英文别名
3-(3-chlorophenyl)-N-methoxy-N-methylprop-2-enamide
3-(3-chloro-phenyl)-N-methoxy-N-methyl-acrylamide化学式
CAS
701914-01-4
化学式
C11H12ClNO2
mdl
MFCD19106648
分子量
225.675
InChiKey
FJQFQXBBSNNOSG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.181
  • 拓扑面积:
    29.5
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    3-(3-chloro-phenyl)-N-methoxy-N-methyl-acrylamideN-((fluoromethyl)(oxo)(phenyl)-λ6-sulfaneylidene)-4-methylbenzenesulfonamidelithium hexamethyldisilazane 作用下, 以 四氢呋喃 为溶剂, 反应 3.33h, 以88%的产率得到(1S,2S,3S)-2-(3-chlorophenyl)-3-fluoro-N-methoxy-N-methyl-cyclopropanecarboxamide
    参考文献:
    名称:
    单氟代环丙烷类化合物及其制备方法和应用
    摘要:
    本发明公开了一种单氟代环丙烷类化合物及其制备方法和应用。本发明的单氟代环丙烷类化合物的结构如式I所示,式中,R1、R2、Ra、的定义如说明书中所述。本发明还提供了一种简单有效的制备单氟代环丙烷类化合物的方法,原料毒性低,得到的产物纯度高。本发明方法不仅能制备消旋的化合物,还可制备非消旋的化合物。本发明的单氟代环丙烷类化合物可进一步用于合成其他环丙烷衍生物。
    公开号:
    CN103373911B
点击查看最新优质反应信息

文献信息

  • Copper-Catalyzed Dehydrogenative Formal [4 + 2] and [3 + 2] Cycloadditions of Methylnaphthalenes and Electron-Deficient Alkenes
    作者:Guiping Qin、Yong Wang、Hanmin Huang
    DOI:10.1021/acs.orglett.7b03194
    日期:2017.12.1
    methylnaphthalenes, which could capture alkyl radicals via SOMO–LUMO interactions, enabled the development of Cu-catalyzed formal [4 + 2] and [3 + 2] cycloadditions between methylnaphthalenes and electron-deficient alkenes. Under copper catalysis, a series of electron-deficient alkenes and methylnaphthalenes with different substituents were successfully incorporated with di-tert-butyl peroxide (TBP) as
    甲基萘中包含的较高π扩展萘可以通过SOMO-LUMO相互作用捕获烷基,从而促进了甲基萘和缺电子烯烃之间铜催化的正式[4 + 2]和[3 + 2]环加成反应的发展。在铜催化下,一系列具有不同取代基的缺电子烯烃和甲基萘已成功地与过氧化二叔丁基(TBP)结合用作氧化剂和自由基引发剂,从而提供了多种环加合物。
  • Arylcyclopropylcarboxylic amides as potassium channel openers
    申请人:——
    公开号:US20040110754A1
    公开(公告)日:2004-06-10
    The present invention provides novel arylcyclopropylcarboxylic amides and related derivatives having the general Formula I 1 wherein R, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are as defined in the specification, or a nontoxic pharmaceutically acceptable salt, solvate or hydrate thereof which are openers or activators of KCNQ potassium channels. The present invention also provides pharmaceutical compositions comprising said arylcyclopropylcarboxylic amides and to the method of treatment of disorders sensitive to KCNQ potassium channel opening activity such as migraine or a migraine attack, bipolar disorders, epilepsy, acute and chronic pain and anxiety.
    本发明提供了具有一般式I1的新型芳基环丙基羧酰胺和相关衍生物,其中R、R1、R2、R3、R4、R5、R6和R7如规范中所定义,或其无毒的药学上可接受的盐、溶剂或水合物,这些化合物是KCNQ钾通道的开启剂或激活剂。本发明还提供了包括上述芳基环丙基羧酰胺的药物组合物,以及治疗对KCNQ钾通道开启活性敏感的疾病的方法,如偏头痛或偏头痛发作、双相障碍、癫痫、急性和慢性疼痛以及焦虑症。
  • Enantioselective Synthesis of Cyclopropanes That Contain Fluorinated Tertiary Stereogenic Carbon Centers: A Chiral α-Fluoro Carbanion Strategy
    作者:Xiao Shen、Wei Zhang、Lei Zhang、Tao Luo、Xiaolong Wan、Yucheng Gu、Jinbo Hu
    DOI:10.1002/anie.201202451
    日期:2012.7.9
    Chiral transfer: The fluorinated sulfoximine (see scheme; Ts=p‐toluenesulfonyl) was synthesized and used as the first chiral fluoromethylenation reagent for the synthesis of cyclopropanes that contain fluorinated tertiary stereogenic carbon centers in good yields, good diastereoselectivity, and excellent enantioselectivity.
    手性转移:合成了氟代亚砜亚胺(见方案; Ts =对甲苯磺酰基),并用作第一个手性氟代甲基化试剂,用于合成具有氟化叔立体碳中心的环丙烷,具有高收率,良好的非对映选择性和出色的对映选择性。
  • Hydrazone Compounds and Their Use
    申请人:STEIN Philip
    公开号:US20110033393A1
    公开(公告)日:2011-02-10
    The present invention relates to hydrazone compounds of Formula I: and pharmaceutically acceptable salts and stereoisomers thereof, wherein R 1 , R 2 , R 3 , R 4 , L 1 , and L 2 are defined as set forth in the specification. The invention is also directed to the use of compounds of Formula I as inhibitors of TRPM5 protein.
    本发明涉及式I的腙化合物及其药用可接受的盐和立体异构体,其中R1、R2、R3、R4、L1和L2的定义如规范中所述。本发明还涉及将式I的化合物用作TRPM5蛋白质的抑制剂。
  • ARYLCYCLOPROPYLCARBOXYLIC AMIDES AS POTASSIUM CHANNEL OPENERS
    申请人:Bristol-Myers Squibb Company
    公开号:EP1565190A2
    公开(公告)日:2005-08-24
查看更多